Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Pascale, Guerre"'
Autor:
Florence Ranchon, Catherine Rioufol, Laure Huot, Pascale Guerre, Guillaume Descotes, Anne-Gaëlle Caffin, Chloé Herledan
Publikováno v:
BMJ Open, Vol 14, Iss 2 (2024)
Introduction The development of oral anticancer agents (OAA) has profoundly changed cancer care, leading patients to manage their chemotherapy treatment on an outpatient basis. The prevention of iatrogenic effects of OAA remains a major concern, espe
Externí odkaz:
https://doaj.org/article/78575a8f0f1647249e5629dfca5636b4
Autor:
Jacques Balosso, Olivia Febvey-Combes, Annie Iung, Hélène Lozano, Abdoulkader Soumai Alloh, Catherine Cornu, Magali Hervé, Zohra Akkal, Michel Lièvre, Valérie Plattner, Francesca Valvo, Cristina Bono, Maria Rosaria Fiore, Viviana Vitolo, Barbara Vischioni, Stéphanie Patin, Hubert Allemand, François Gueyffier, Jennifer Margier, Pascale Guerre, Sylvie Chabaud, Roberto Orecchia, Pascal Pommier
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Some cancers such as sarcomas (bone and soft tissue sarcomas) and adenoid cystic carcinomas are considered as radioresistant to low linear energy transfer radiation (including photons and protons) and may therefore beneficiate fro
Externí odkaz:
https://doaj.org/article/3119fabd3a0e4996a4ce486fb8566547
Autor:
Abdelbaste Hrifach, Christell Ganne, Sandrine Couray-Targe, Coralie Brault, Pascale Guerre, Hassan Serrier, Hugo Rabier, Gwen Grguric, Pierre Farge, Cyrille Colin
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 16, Iss 1, Pp 1-7 (2018)
Abstract Background The choice of cost data sources is crucial, because it influences the results of cost studies, decisions of hospital managers and ultimately national directives of policy makers. The main objective of this study was to compare a h
Externí odkaz:
https://doaj.org/article/ae25985690194a2bbd1540c3dd8d99e3
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 23:273-280
Autor:
Audrey de Parisot, Yvan Jamilloux, Laurent Kodjikian, Marie-Hélène Errera, Neila Sedira, Emmanuel Heron, Laurent Pérard, Pierre-Loïc Cornut, Christelle Schneider, Sophie Rivière, Priscille Ollé, Grégory Pugnet, Pascal Cathébras, Pierre Manoli, Bahram Bodaghi, David Saadoun, Stéphanie Baillif, Nathalie Tieulie, Marc André, Frédéric Chiambaretta, Nicolas Bonin, Philip Bielefeld, Alain Bron, Frédéric Mouriaux, Boris Bienvenu, Nassira Amamra, Pascale Guerre, Evelyne Decullier, Pascal Sève, ULISSE group
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0228918 (2020)
MAIN OBJECTIVE:To prospectively assess the cost-consequence of a standardized diagnostic strategy as to compared to an open one for the etiological diagnosis of uveitis. DESIGN:This was a prospective, non-inferiority, multicentre, randomized controll
Externí odkaz:
https://doaj.org/article/9e4db925e0234baa9c9ea9ebbb8b2a95
Publikováno v:
Blood Coagulation & Fibrinolysis. 33:119-123
The aim of the present study was to perform an economic evaluation of two alternative assays of ADAMTS13 activity (A Disintegrin And Metalloprotease with ThromboSpondin type 1 repeats, member 13) for diagnosing thrombotic thrombocytopenic purpura (TT
Autor:
Steven Le Gouill, Laure Huot, Pascale Guerre, Clémentine Fronteau, Vérane Schwiertz, Emilie Fargier, Arthur Dony, Violaine Safar, Stéphane Savouroux, Emmanuel Gyan, Jean-François Tournamille, Nicolas Vantard, Patrick Tomaré, Catherine Rioufol, Emmanuel Bachy, Florence Ranchon, Gilles Salles, Nathalie Hequet
Publikováno v:
Annals of Hematology. 97:123-131
Rituximab is used as a standard of care for follicular lymphoma and is usually administered intravenously. A novel subcutaneous formulation recently showed non-inferior efficacy with similar pharmacokinetic and safety profiles compared to intravenous
Autor:
Cyrille Colin, Michel Ovize, Hugo Rabier, Anne-Marie Schott, Antoine Duclos, Marie Viprey, Norbert Nighoghossian, Gwen Grguric, Marine Barral, Pascale Guerre, Christell Julien, Jennifer Margier, Jessica Dalaudiere, Hassan Serrier, Asma Fares, Nathan Mewton
Publikováno v:
International Journal of Technology Assessment in Health Care
International Journal of Technology Assessment in Health Care, Cambridge University Press (CUP), 2020, 36 (3), pp.245--251. ⟨10.1017/s0266462320000148⟩
International Journal of Technology Assessment in Health Care, 2020, 36 (3), pp.245--251. ⟨10.1017/s0266462320000148⟩
International Journal of Technology Assessment in Health Care, Cambridge University Press (CUP), 2020, 36 (3), pp.245--251. ⟨10.1017/s0266462320000148⟩
International Journal of Technology Assessment in Health Care, 2020, 36 (3), pp.245--251. ⟨10.1017/s0266462320000148⟩
ObjectivesThe aim of the study was to measure the economic impact of informal care (IC) on caregivers assisting myocardial infarction (MI) survivors in France. Health and social impacts were also described.MethodsData from the prospective 2008 Health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be1e7259c01ebea4533f68b4dcecd2d2
https://hal.archives-ouvertes.fr/hal-02902521
https://hal.archives-ouvertes.fr/hal-02902521
Autor:
Abdelbaste Hrifach, Cyrille Colin, Hassan Serrier, Hugo Rabier, Pascale Guerre, Jean-François Obadia, Christell Julien, Nermine Laaboub, Daniel Grinberg
Publikováno v:
Int J Technol Assess Health Care
Int J Technol Assess Health Care, 2019, 35 (1), pp.45--49. ⟨10.1017/s0266462318003768⟩
International Journal of Technology Assessment in Health Care
International Journal of Technology Assessment in Health Care, Cambridge University Press (CUP), 2019, 35 (1), pp.45--49. ⟨10.1017/s0266462318003768⟩
Int J Technol Assess Health Care, 2019, 35 (1), pp.45--49. ⟨10.1017/s0266462318003768⟩
International Journal of Technology Assessment in Health Care
International Journal of Technology Assessment in Health Care, Cambridge University Press (CUP), 2019, 35 (1), pp.45--49. ⟨10.1017/s0266462318003768⟩
ObjectivesCardiac surgery has seen substantial scientific progress over recent decades. Health economic evaluations have become important tools for decision makers to prioritize scarce health resources. The present study aimed to identify and critica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d97100476ac2f939ef447391f13d58f4
https://hal.archives-ouvertes.fr/hal-02195245
https://hal.archives-ouvertes.fr/hal-02195245
Autor:
Pascale Guerre, Christell Ganne, Coralie Brault, Pierre Farge, Abdelbaste Hrifach, Hassan Serrier, Cyrille Colin, Sandrine Couray-Targe
Publikováno v:
European journal of public health. 28(3)
Background Organ recovery costs should be assessed to allow efficient and sustainable integration of these costs into national healthcare budgets and policies. These costs are of considerable interest to health economists, hospitals, financial manage